The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Drug prices are up for negotiation on 15 Medicare Part D prescription drugs, including popular weight loss drugs such as Ozempic.

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

The media mogul's comments about weight loss drugs and "thin people" have stirred intense reactions across social media ...

The Trump administration’s first drug pricing action — rescinding a Biden executive order encouraging Medicare to help lower ...

Such vulnerabilities reveal systemic weaknesses, especially when drugs like Wegovy should only be prescribed under close clinical supervision. A significant concern is the prescription of Wegovy ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated ...